Intratracheal Budesonide/Surfactant Prevents BPD

PHASE4CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Respiratory Distress SyndromeBronchopulmonary Dysplasia
Interventions
DRUG

budesonide

Intra-tracheal instillation of a combination of budesonide/surfactant in preterm infants with RDS to prevent BPD

DRUG

Saline

Intra-tracheal instillation of a combination of saline/surfactant in preterm infants with RDS to prevent BPD

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

Taipei Medical University Hospital

OTHER

collaborator

National Taiwan University Hospital

OTHER

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Mackay Memorial Hospital

OTHER

collaborator

Chang Gung Memorial Hospital

OTHER

collaborator

China Medical University Hospital

OTHER

collaborator

Seventh Medical Center of PLA General Hospital

OTHER

collaborator

Guangzhou Women and Children's Medical Center

OTHER

collaborator

Taichung Veterans General Hospital

OTHER

lead

Taipei Medical University

OTHER

NCT03275415 - Intratracheal Budesonide/Surfactant Prevents BPD | Biotech Hunter | Biotech Hunter